Additionally, NTG has been investigated in the context of cerebral ischemia; however, outcomes in ischemic stroke therapy remain inconsistent, highlighting the need for further research to clarify its neuroprotective potential (23). The gene discussed is OPA1; the disease is Cerebral ischemia.